The clinical implications of serum ferritin in Kawasaki disease: a helpful biomarker for evaluating therapeutic responsiveness, coronary artery involvement and the tendency of macrophage activation syndromeARCHIVES OF MEDICAL SCIENCEIF3.32021-12-086OAAI
A new scoring system for coronary artery abnormalities in Kawasaki diseasePEDIATRIC RESEARCHIF3.12021-09-2811OAAI
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsivenessCLINICAL AND EXPERIMENTAL MEDICINEIF3.52021-04-1113OAAI
Scabies, incomplete lupus erythematosus and Henoch-Schonlein purpuraARCHIVES OF MEDICAL SCIENCEIF3.32021-03-011OAAI
Assessment of coronary artery abnormalities and variability ofZ-score calculation in the acute episode of Kawasaki disease-A retrospective study from ChinaEUROPEAN JOURNAL OF CLINICAL INVESTIGATIONIF3.62020-09-258PREAI
Clinical observation of noncoronary cardiac abnormalities in Chinese children with Kawasaki diseaseEUROPEAN JOURNAL OF CLINICAL INVESTIGATIONIF3.62020-03-1711PREAI
Hepatic dysfunction secondary to Kawasaki disease: characteristics, etiology and predictive role in coronary artery abnormalitiesCLINICAL AND EXPERIMENTAL MEDICINEIF3.52019-11-1627PREAI
C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23/MAPK signalingEXPERIMENTAL AND MOLECULAR MEDICINEIF12.92019-07-018OAAI
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysmInterleukin-6倾向于成为预测不完全和IVIG无反应性川崎病而不是冠状动脉瘤的候选生物标志物CLINICAL AND EXPERIMENTAL MEDICINEIF3.52019-01-0847PREAI